Advertisement

Advertisement

HotelsFoodShoppingCoffeeGroceryGas

Monte Rosa Therapeutics, Inc

+1 (617) 949-2643
Website

Advertisement

Advertisement

321 Harrison Ave Ste 900
Boston, MA 02118
+1 (617) 949-2643
https://www.monterosatx.com

Monte Rosa Therapeutics, Inc is a biotechnology company based in Boston, MA that specializes in drug discovery and development.

Utilizing innovative technologies, Monte Rosa Therapeutics is dedicated to advancing novel therapies for the treatment of various diseases.

Generated from their business information

Also at this address

Advantest Corp

PepGen, Inc

Pyxis Oncology, Inc

HilleVax, Inc

Own this business?
Claim it
See a problem?

You might also like

PepGen, Inc

PepGen Inc is a Boston-based biotechnology company focused on developing a new generation of disease-modifying therapies for serious genetic neuromuscular and neurological disorders. Powered by their proprietary Enhanced Delivery Oligonucleotide (EDO) platform, they are committed to creating transformative therapies that target the root cause of these disorders. With a pioneering approach to genetic therapies, PepGen is advancing a robust pipeline of therapeutics to treat conditions such as Duchenne Muscular Dystrophy (DMD) and Myotonic Dystrophy Type 1 (DM1). Their dedication to the community drives their mission to improve the lives of individuals living with neuromuscular and neurological disorders.Generated from the website
Internal medicine practitioners

Pyxis Oncology, Inc

Pyxis Oncology, Inc., located in Boston, is dedicated to developing therapeutics for difficult-to-treat cancers. The company is focused on charting a course towards innovative solutions to address the challenges of these complex diseases. Generated from their website's infomation
Drugs and drug proprietaries

Paratek Pharmaceuticals Inc

Paratek Pharmaceuticals, based in Boston, MA, is a biopharmaceutical company dedicated to addressing the critical global public health issue of antimicrobial resistance (AMR). With a focus on developing innovative treatment options for complex medical issues, Paratek is committed to combatting AMR through responsible antibiotic use, improved surveillance, and research into new antibiotics. Grounded in a mission to save lives, Paratek's FDA-approved tetracycline-class antibiotic, NUZYRA, targets adult patients with community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible bacteria. The company's disciplined team of experts is driven to provide new technologies that can defeat superbugs and contribute to a vibrant marketplace that recognizes the life-saving value of novel antibiotics.Generated from the website
United States›Massachusetts›Boston›Monte Rosa Therapeutics, Inc

Partial Data by Infogroup (c) 2024. All rights reserved.

Advertisement

Advertisement

  • Get directions
  • MapQuest Travel
  • Route Planner
  • Print your map
  • Get help
  • Search the web
  • Send feedback
Learn more about our mobile apps.
  • Android app Google Play
  • Download on the App Store
  • Download on the Amazon Appstore
  • Enterprise solutions
  • Claim your business
  • Developer resources
  • Jobs
  • Advertise with us
  • Terms of use
  • Privacy policy
  • Data and licenses
  • About our ads
  • Do not sell